Adherence to the study product was insufficient to demonstrate the effectiveness of FTC/TDF in 2 PrEP clinical trials conducted among women ( FEM-PrEP and the Vaginal and Oral Interventions to Control the Epidemic study ) , but further analyses of adherence in these studies may inform PrEP demonstration projects and future HIV prevention clinical trials .